Filing Flows › Comparisons › NAMS vs FBIO
NewAmsterdam Pharma Co N.V. vs Fortress Biotech: NAMS and FBIO compared
NewAmsterdam Pharma Co N.V. is the larger company: $19.2M of revenue in its latest quarter (Q3 2026) against $18.7M for Fortress Biotech (Q2 2026). NewAmsterdam Pharma Co N.V. is growing faster (55× against +14% a year earlier). Fortress Biotech is more profitable, with an operating margin of -53.5% against -230.6%.
Where the money goes: NAMS and FBIO
NewAmsterdam Pharma Co N.V. (NAMS) · Q3 2026
NewAmsterdam Pharma Co N.V., Q3 2026: revenue $19.2M (55× year over year), operating margin -230.6%, net loss $17.4M, operating cash flow −$39.8M. The chart follows the revenue to costs, profit and cash.
Fortress Biotech (FBIO) · Q2 2026
Fortress Biotech, Q2 2026: revenue $18.7M (+14% year over year), operating margin -53.5%, net earnings $602K, operating cash flow −$59.3M. The chart follows the revenue to costs, profit and cash.
| NewAmsterdam Pharma Co N.V. (NAMS) | Fortress Biotech (FBIO) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $19.2M | $18.7M |
| Revenue growth, Y/Y | 55× | +14% |
| Operating margin | -230.6% | -53.5% |
| Net earnings | −$17.4M | $602K |
| Net margin | -90.7% | 3.2% |
| Operating cash flow | −$39.8M | −$59.3M |
Where the revenue comes from
Fortress Biotech
- Journey: $18.5M (99%)
- Fortress: $208K (1%)
Questions
Which is bigger, NewAmsterdam Pharma Co N.V. or Fortress Biotech?
NewAmsterdam Pharma Co N.V. is the larger company: $19.2M of revenue in its latest quarter (Q3 2026) against $18.7M for Fortress Biotech (Q2 2026).
Is NewAmsterdam Pharma Co N.V. or Fortress Biotech growing faster?
NewAmsterdam Pharma Co N.V. is growing faster (55× against +14% a year earlier).
Which is more profitable, NewAmsterdam Pharma Co N.V. or Fortress Biotech?
Fortress Biotech is more profitable, with an operating margin of -53.5% against -230.6%.
More: NewAmsterdam Pharma Co N.V. earnings · how NewAmsterdam Pharma Co N.V. makes money · Fortress Biotech earnings · how Fortress Biotech makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.